Effects of desmopressin and dextran on coagulation and fibrinolysis in healthy volunteers
- PMID: 1716790
- DOI: 10.1016/0049-3848(91)90009-l
Effects of desmopressin and dextran on coagulation and fibrinolysis in healthy volunteers
Abstract
The effects of desmopressin and dextran on haemostasis and fibrinolysis were studied in four healthy volunteers. Both drugs were compared to placebo, each volunteer being subject to four experiments. Dextran 70 (30 g i.v.) moderately decreased VIII:C and vWF:Ag and slightly increased antithrombin III, also when haemodilution and diurnal variation were considered. Desmopressin (0.3 micrograms/kg BW i.v.), alone as well as in combination with dextran, increased VIII: C, vWF:Ag, protein C and tPA and decreased PAI-1. The combination of desmopressin and dextran stimulated coagulation and fibrinolysis and might be of relevance to surgical blood loss as well as to postoperative thromboembolism.
Similar articles
-
Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement.Thromb Haemost. 1991 Dec 2;66(6):652-6. Thromb Haemost. 1991. PMID: 1796409 Clinical Trial.
-
1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.Neth J Med. 1993 Aug;43(1-2):5-12. Neth J Med. 1993. PMID: 8232694 Clinical Trial.
-
Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanisms.Acta Chir Scand. 1990 Sep;156(9):597-602. Acta Chir Scand. 1990. PMID: 1702252
-
Desmopressin (DDAVP) for treatment of disorders of hemostasis.Prog Hemost Thromb. 1986;8:19-45. Prog Hemost Thromb. 1986. PMID: 3104987 Review.
-
Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.Drugs. 2003;63(17):1821-54. doi: 10.2165/00003495-200363170-00005. Drugs. 2003. PMID: 12921488 Review.
Cited by
-
Anaesthetic implications of 32% Dextran-70 (Hyskon) during hysteroscopy: hysteroscopy syndrome.Can J Anaesth. 1992 Nov;39(9):975-9. doi: 10.1007/BF03008349. Can J Anaesth. 1992. PMID: 1280535 Review.
-
Plasma proteomics in patients with von Willebrand disease and hemophilia A highlights von Willebrand factor as main determinant of response to desmopressin treatment.Res Pract Thromb Haemost. 2025 Mar 19;9(3):102738. doi: 10.1016/j.rpth.2025.102738. eCollection 2025 Mar. Res Pract Thromb Haemost. 2025. PMID: 40290674 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous